Welcome to our dedicated page for Bunge Global SA SEC filings (Ticker: BG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bunge Global SA filings document the regulatory record of a Swiss-incorporated agribusiness company with registered shares listed on the New York Stock Exchange under BG. Its disclosures cover operating and financial results, material events, proxy governance, shareholder voting matters and capital-structure changes.
The company's recent 8-K filings include amendments to a trade receivables securitization program, executive compensation arrangements tied to integration efforts, amendments to its Articles of Association following share cancellations, and exhibits for results releases. Proxy materials address board governance, voting matters, executive compensation and other shareholder disclosures, while material-event reports also document integration and risk-related information following completed acquisitions.
Podwika Joseph reported acquisition or exercise transactions in this Form 4 filing.
Bunge Global SA Chief Legal Officer Joseph Podwika received an award of 130 shares of common stock valued at $126.92 per share. The award represents restricted stock units credited on June 1, 2026 under the company’s long-term incentive plans due to a dividend feature. Following this grant, his direct holdings total 92,132 shares of common stock.
Bunge Global SA director Henry Ward Winship IV acquired 9 restricted stock units of common stock on June 1, 2026. These units were credited under a dividend feature of the company’s long-term incentive plans and represent a compensation-related award, not an open-market purchase. After this grant, he directly holds 34,472.7968 shares or share-equivalent units.
Bunge Global SA director Linda P. Jojo reported a small equity award tied to the company’s dividend program. On June 1, 2026, she acquired 9 shares of common stock at a reported value of $126.92 per share.
The filing explains these represent restricted stock units credited under Bunge’s long-term incentive plans through a dividend feature, meaning she received additional units instead of cash dividends. Following this award, her directly held common stock position reported in the filing increased to 3,602 shares, reflecting routine, compensation-related activity rather than an open-market trade.
Jensen Anne reported acquisition or exercise transactions in this Form 4 filing.
Bunge Global SA director Anne Jensen reported an award of 9 shares of Common Stock on June 1, 2026. These were restricted stock units credited under a dividend feature in the company’s long-term incentive plans, not an open-market purchase. Following this grant, she holds 3,320 shares directly.
Director Adrian Isman of Bunge Global SA reported an acquisition of 9 shares of common stock on June 1, 2026. These shares represent restricted stock units received pursuant to a dividend feature under the company’s long-term incentive plans. Following this grant, Isman directly holds 3,320 common shares.
Bunge Global SA director Walt Markus received a small equity award. On June 1, 2026, he acquired 9 shares of Common Stock as restricted stock units under the company’s long-term incentive plans via a dividend feature. After this award, he directly holds 3,736 shares of Common Stock.
Bunge Global SA director Eliane Aleixo Lustosa de Andrade received additional equity compensation through the company’s incentive plan. On June 1, 2026, she acquired 9 restricted stock units tied to Bunge common stock, valued at $126.92 per share, pursuant to a dividend feature under the company’s long-term incentive plans. Following this award, her direct holdings total 7,282 shares of common stock.
Bunge Global SA Chief Operating Officer Julio Garros reported an acquisition of 237 shares of common stock on June 1, 2026. These were restricted stock units granted at a reference price of $126.92 per share, received through a dividend feature under Bunge’s long-term incentive plans, rather than an open-market purchase.
After this award, Garros directly holds about 142,646.321 shares of Bunge common stock. The transaction reflects routine, compensation-related equity accumulation tied to the company’s incentive programs, with no shares sold in this filing.
Mahoney Christopher reported acquisition or exercise transactions in this Form 4 filing.
Bunge Global SA director Christopher Mahoney received an equity award tied to company stock. The filing shows a grant of 1,654 shares of common stock in the form of Restricted Stock Units, which are expected to vest in full on May 20, 2027. After this award, Mahoney directly holds 8,311 shares of Bunge common stock. This appears to be a routine director compensation grant rather than an open-market purchase or sale.
Bunge Global SA director Henry Ward Winship IV received an equity award of 1,654 Restricted Stock Units (RSUs) tied to Bunge common stock. Each RSU converts into one share, and the award is expected to vest in full on May 20, 2027. Following this grant, he holds a total of 34,463.7968 shares of common stock directly.